Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Hemophilia B Gene Therapy - Spark

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2014 by Spark Therapeutics, LLC
Sponsor:
Collaborators:
Children's Hospital of Philadelphia
University of Pittsburgh
Royal Prince Alfred Hospital, Sydney, Australia
St. James's Hospital, Ireland
Information provided by (Responsible Party):
Spark Therapeutics, LLC
ClinicalTrials.gov Identifier:
NCT01620801
First received: June 12, 2012
Last updated: October 31, 2014
Last verified: October 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: October 2029
  Estimated Primary Completion Date: October 2019 (Final data collection date for primary outcome measure)